Opioid-Induced Hypoglycemia in Diabetes: Dose-Dependent Effects of Methadone in a Complex Chronic Pain Patient

Methadone is a widely used opioid for the management of chronic pain and opioid use disorder. Despite its safety profile, it is complicated by rare but significant side effects that can be easily overlooked in patients with multiple comorbidities. This case report details a challenging scenario of persistent hypoglycemia in a patient with a complex history of chronic pain syndrome, failed back surgery, and type 2 diabetes mellitus, who was maintained on high-dose methadone for pain control. Despite persistent hyperglycemia (glucose = 165-245 mg/dL, hemoglobin A1c = 7.0-8.1%) and the need for frequent insulin dose adjustments due to poor glycemic control, the patient experienced recurrent episodes of overnight hypoglycemia despite insulin administration for carbohydrate intake. The paradox of hyperglycemia with intermittent hypoglycemia was attributed to methadone use, with hypoglycemia episodes noted to be dose-dependent at methadone doses exceeding 40 mg daily. The patient's endocrine comorbidities, including hypothyroidism and hypogonadism, further complicated glucose homeostasis and counter-regulatory responses. This case signifies the importance of maintaining a high index of suspicion of opioid-induced hypoglycemia in patients with diabetes and chronic pain, especially in the context of escalating methadone therapy. It highlights the need for individualized management strategies when multiple risk factors are present.